Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
EMBO J ; 37(20)2018 10 15.
Article in English | MEDLINE | ID: mdl-30217955

ABSTRACT

Uncontrolled cell division is a hallmark of cancer. Deregulation of Wnt components has been linked to aberrant cell division by multiple mechanisms, including Wnt-mediated stabilisation of proteins signalling, which was notably observed in mitosis. Analysis of Wnt components revealed an unexpected role of B-cell CLL/lymphoma 9 (BCL9) in maintaining mitotic Wnt signalling to promote precise cell division and growth of cancer cell. Mitotic interactome analysis revealed a mechanistic role of BCL9 in inhibiting clathrin-mediated degradation of LRP6 signalosome components by interacting with clathrin and the components in Wnt destruction complex; this function was further controlled by CDK1-driven phosphorylation of BCL9 N-terminal, especially T172. Interestingly, T172 phosphorylation was correlated with cancer patient prognosis and enriched in tumours. Thus, our results revealed a novel role of BCL9 in controlling mitotic Wnt signalling to promote cell division and growth.


Subject(s)
CDC2 Protein Kinase/metabolism , Clathrin/metabolism , Mitosis , Neoplasm Proteins/metabolism , Neoplasms/metabolism , Wnt Signaling Pathway , HCT116 Cells , HeLa Cells , Humans , Low Density Lipoprotein Receptor-Related Protein-6/metabolism , Neoplasms/pathology , Phosphorylation , Protein Domains , Transcription Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...